We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A phase 2 clinical program for the third generation of ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results